Brief: Somnomed Sees Fy22 Revenue Growth Of At Least 15%
25/11/2021 01:13
Nov 25 (Reuters) - Somnomed Ltd SOM.AX :
* SEES FY22 REVENUE GROWTH OF AT LEAST 15%
* SEES FY22 EBITDA TO BREAK EVEN, EXPECTED TO REBOUND IN
FY23 AND
BEYOND
Source text for Eikon: ID:nASX4hm5Wt
Further company coverage: SOM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SomnoMed
See all newsAustralia's Somnomed jumps most in 7 months on strong half-year earnings
Brief: Somnomed® Increases Investment In Managed Care Infrastructure
Australia's Somnomed hits 32-month high on upbeat revenue growth
Brief: Somnomed Says Q1 FY26 Revenue Up 13.5% To A$28.7 Million
Brief: Somnomed Says FY EBITDA AUD 9.2 Million